Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children
Most Cited Paper
in Pediatric health and respiratory diseases
18 Months Post-Publication
Class of 2026
“Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026/
Topics
nirsevimab · Respiratory syncytial virus · RSV lower respiratory tract infection · immunocompromised children · extended half-life monoclonal antibody · MUSIC trial · pharmacokinetics · Primary immunodeficiency · transplantation · HIV infection · high-dose systemic corticosteroids · immunosuppressive chemotherapy · antidrug antibodies · nirsevimab clearance · protein loss · intramuscular injection · serum concentrations
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459